|
Volumn 19, Issue 1, 2015, Pages
|
Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: We still need to straighten out the dose!
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE;
COLISTIMETHATE;
COLISTIN;
ANTIINFECTIVE AGENT;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
GRAM NEGATIVE BACTERIUM;
HIGH RISK PATIENT;
HUMAN;
KIDNEY INJURY;
LETTER;
LUNG INFECTION;
MONOTHERAPY;
MULTIDRUG RESISTANCE;
NONHUMAN;
PRIORITY JOURNAL;
VENTILATOR ASSOCIATED PNEUMONIA;
ADVERSE EFFECTS;
ARTIFICIAL VENTILATION;
NEBULIZER;
PNEUMONIA, VENTILATOR-ASSOCIATED;
ANTI-BACTERIAL AGENTS;
HUMANS;
NEBULIZERS AND VAPORIZERS;
PNEUMONIA, VENTILATOR-ASSOCIATED;
RESPIRATION, ARTIFICIAL;
|
EID: 84933042413
PISSN: 13648535
EISSN: 1466609X
Source Type: Journal
DOI: 10.1186/s13054-015-0966-x Document Type: Letter |
Times cited : (2)
|
References (5)
|